RP
VMD icon

Raelipskie Partnership’s Viemed Healthcare VMD Stock Holding History

Raelipskie Partnership’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$943 – 103
2024
Q1 		$943 Buy
+100
New +$857 ﹤0.01% 97

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raelipskie Partnership's VMD Position: Q2 2024 in Review

Raelipskie Partnership sold out of Viemed Healthcare (VMD) in Q2 2024, closing a stake of 100 shares — an estimated $943 sold.

Raelipskie Partnership first reported a position in VMD in Q1 2024 and held it in 1 quarter. The position peaked at $943 in Q1 2024. 116 funds tracked by Wall St. Rank hold VMD as of Q2 2024.

  • Raelipskie Partnership reported no remaining Viemed Healthcare position as of Q2 2024 after selling out during the quarter.
  • Raelipskie Partnership sold 100 Viemed Healthcare shares in Q2 2024, an estimated $943.
  • Raelipskie Partnership first reported a position in Viemed Healthcare in Q1 2024 and held it in 1 quarter.
  • Raelipskie Partnership's Viemed Healthcare position peaked at $943 in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2024.

Based on Raelipskie Partnership's 13F filing for Q2 2024, filed 18 Jul 2024.